Table 3

Main characteristics of the subjects considered in the analysis according to the GOLD severity stages, and crude relative risk ratios (RRR)* with 95% confidence intervals for the association between each risk factor and the GOLD severity stage

No respiratory disorders (n = 12567) %Stage 0 (n = 1751)Stages I+ (n = 537)
%RRR (95% CI)%RRR (95% CI)
*Calculated by multinomial regression models (reference population: subjects with neither chronic symptoms nor airflow obstruction).
†ETS+/−: subjects exposed/not exposed to environmental tobacco smoke.
‡Cigars, cigarillos or pipe tobacco.
Active/passive smoking exposure:
    Non-smokers and ETS−†37.921.41.0024.01.00
    Past smokers and ETS−17.310.21.05 (0.87 to 1.27)15.61.42 (1.07 to 1.89)
    Non-smokers and ETS+7.55.41.29 (1.02 to 1.64)5.01.06 (0.69 to 1.62)
    Past smokers and ETS+4.43.11.23 (0.91 to 1.67)4.01.45 (0.91 to 2.33)
    Smokers (<15 pack years)19.928.52.55 (2.20 to 2.94)14.41.15 (0.86 to 1.53)
    Smokers (⩾15 pack years)11.530.14.65 (4.01 to 5.38)33.54.58 (3.62 to 5.81)
    Smokers (other tobaccos)‡1.51.31.47 (0.93 to 2.31)3.53.50 (2.09 to 5.86)
Presence of respiratory infections before the age of 5 years8.912.21.47 (1.26 to 1.72)14.11.71 (1.32 to 2.20)
Presence of occupational exposure to vapours, gas, dust or fumes in a lifetime41.654.41.67 (1.51 to 1.85)52.31.54 (1.29 to 1.83)
Low socioeconomic class19.529.01.68 (1.50 to 1.89)28.01.60 (1.30 to 1.97)
Females51.146.333.7
Mean (SD) age (years)33.6 (7.2)33.2 (7.1)36.8 (6.5)
Mean (SD) FEV1 % predicted106.6 (13.1)103.9 (13.1)86.6 (15.1)